Clinical, Pathological, and Genetic Characteristics of Patients with Digenic Alport Syndrome

Overview

Journal Kidney360

Specialty Nephrology

Date 2024 Aug 13

PMID 39137047

Authors

Yuta Inoki

Tomoko Horinouchi

Tomohiko Yamamura

Shingo Ishimori

Yuta Ichikawa

Yu Tanaka

Chika Ueda

Hideaki Kitakado

Atsushi Kondo

Nana Sakakibara

China Nagano

Kandai Nozu

Affiliations

Soon will be listed here.

References

Mencarelli M, Heidet L, Storey H, van Geel M, Knebelmann B, Fallerini C . Evidence of digenic inheritance in Alport syndrome. J Med Genet. 2015; 52(3):163-74. DOI: 10.1136/jmedgenet-2014-102822. View

Choi M, Anistan Y, Eckardt K, Gollasch M, Nickel P . Possible Digenic Disease in a Caucasian Family with COL4A3 and COL4A5 Mutations. Nephron. 2019; 141(3):213-218. DOI: 10.1159/000495764. View

Alport A . HEREDITARY FAMILIAL CONGENITAL HAEMORRHAGIC NEPHRITIS. Br Med J. 2010; 1(3454):504-6. PMC: 2454341. DOI: 10.1136/bmj.1.3454.504. View

Kashtan C . Alport syndrome and thin glomerular basement membrane disease. J Am Soc Nephrol. 1998; 9(9):1736-50. DOI: 10.1681/ASN.V991736. View

Savige J, Storey H, Watson E, Hertz J, Deltas C, Renieri A . Consensus statement on standards and guidelines for the molecular diagnostics of Alport syndrome: refining the ACMG criteria. Eur J Hum Genet. 2021; 29(8):1186-1197. PMC: 8384871. DOI: 10.1038/s41431-021-00858-1. View

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J . Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015; 17(5):405-24. PMC: 4544753. DOI: 10.1038/gim.2015.30. View

Fallerini C, Baldassarri M, Trevisson E, Morbidoni V, La Manna A, Lazzarin R . Alport syndrome: impact of digenic inheritance in patients management. Clin Genet. 2016; 92(1):34-44. DOI: 10.1111/cge.12919. View

Kamiyoshi N, Nozu K, Fu X, Morisada N, Nozu Y, Ye M . Genetic, Clinical, and Pathologic Backgrounds of Patients with Autosomal Dominant Alport Syndrome. Clin J Am Soc Nephrol. 2016; 11(8):1441-1449. PMC: 4974872. DOI: 10.2215/CJN.01000116. View

Savige J, Renieri A, Ars E, Daga S, Pinto A, Rothe H . Digenic Alport Syndrome. Clin J Am Soc Nephrol. 2022; 17(11):1697-1706. PMC: 9718039. DOI: 10.2215/CJN.03120322. View

10.

Gibson J, Fieldhouse R, Chan M, Sadeghi-Alavijeh O, Burnett L, Izzi V . Prevalence Estimates of Predicted Pathogenic Variants in a Population Sequencing Database and Their Implications for Alport Syndrome. J Am Soc Nephrol. 2021; 32(9):2273-2290. PMC: 8729840. DOI: 10.1681/ASN.2020071065. View

11.

Kruegel J, Rubel D, Gross O . Alport syndrome--insights from basic and clinical research. Nat Rev Nephrol. 2012; 9(3):170-8. DOI: 10.1038/nrneph.2012.259. View

12.

Yamamura T, Nozu K, Fu X, Nozu Y, Ye M, Shono A . Natural History and Genotype-Phenotype Correlation in Female X-Linked Alport Syndrome. Kidney Int Rep. 2017; 2(5):850-855. PMC: 5733817. DOI: 10.1016/j.ekir.2017.04.011. View

13.

Savige J, Storey H, Cheong H, Kang H, Park E, Hilbert P . X-Linked and Autosomal Recessive Alport Syndrome: Pathogenic Variant Features and Further Genotype-Phenotype Correlations. PLoS One. 2016; 11(9):e0161802. PMC: 5023110. DOI: 10.1371/journal.pone.0161802. View

14.

Yamamura T, Horinouchi T, Nagano C, Omori T, Sakakibara N, Aoto Y . Genotype-phenotype correlations influence the response to angiotensin-targeting drugs in Japanese patients with male X-linked Alport syndrome. Kidney Int. 2020; 98(6):1605-1614. DOI: 10.1016/j.kint.2020.06.038. View

15.

Jais J, Knebelmann B, Giatras I, Marchi M, Rizzoni G, Renieri A . X-linked Alport syndrome: natural history in 195 families and genotype- phenotype correlations in males. J Am Soc Nephrol. 2000; 11(4):649-657. DOI: 10.1681/ASN.V114649. View

16.

Uemura O, Nagai T, Ishikura K, Ito S, Hataya H, Gotoh Y . Creatinine-based equation to estimate the glomerular filtration rate in Japanese children and adolescents with chronic kidney disease. Clin Exp Nephrol. 2013; 18(4):626-33. DOI: 10.1007/s10157-013-0856-y. View

17.

Horinouchi T, Nozu K, Yamamura T, Minamikawa S, Omori T, Nakanishi K . Detection of Splicing Abnormalities and Genotype-Phenotype Correlation in X-linked Alport Syndrome. J Am Soc Nephrol. 2018; 29(8):2244-2254. PMC: 6065097. DOI: 10.1681/ASN.2018030228. View

18.

Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K . Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis. 2009; 53(6):982-92. DOI: 10.1053/j.ajkd.2008.12.034. View

19.

Furlano M, Martinez V, Pybus M, Arce Y, Crespi J, Venegas M . Clinical and Genetic Features of Autosomal Dominant Alport Syndrome: A Cohort Study. Am J Kidney Dis. 2021; 78(4):560-570.e1. DOI: 10.1053/j.ajkd.2021.02.326. View

20.

Yokota K, Nozu K, Minamikawa S, Yamamura T, Nakanishi K, Kaneda H . Female X-linked Alport syndrome with somatic mosaicism. Clin Exp Nephrol. 2016; 21(5):877-883. DOI: 10.1007/s10157-016-1352-y. View